A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane

The recruitment status of this study is unknown because the information has not been verified recently.

Verified November 2004 by Genentech.
Recruitment status was Active, not recruiting

Sponsor:

Information provided by:

Genentech

ClinicalTrials.gov Identifier:

NCT00097487

First received: November 24, 2004

Last updated: June 23, 2005

Last verified: November 2004

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2004
Estimated Primary Completion Date:	No date given